Maintenance Service for two (2) Illumina NextSeq™ 1000 Sequencers
Closed Pre-Solicitation Posted
- Solicitation number
- NIH-CC-OPC-25-000192
- Agency
-
NIH Clinical Center
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 811210 Electronic and Precision Equipment Repair and Maintenance
- Place of performance
- Bethesda, Maryland 20892, United States
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institutes of Health Clinical Center (NIH CC) intends to award a firm-fixed price purchase order to Illumina, Inc. on a sole source basis to provide maintenance service for two Illumina NextSeq 1000 Sequencers. The instruments are used to perform high-throughput, next-generation sequencing to diagnose inherited immune disorders. The requirements include full coverage for parts, labor, and travel, reagent replacement, technical support, and software/hardware updates. Illumina is the sole manufacturer and the only known provider with access to the necessary components, spare parts, and technical expertise to maintain the original operating specifications of the instruments. This acquisition will be conducted using simplified acquisition procedures, and no solicitation document will be issued. Interested parties may submit capability statements outlining their ability to provide the same products or services, and the government will evaluate the responses to determine if a competitive procurement is warranted.
This acquisition is not set aside for any particular business category. Illumina, Inc. is the current incumbent and the only known provider of the required maintenance services. No specific award value or budget range is provided, as this will be a firm-fixed price purchase order. The period of performance will be for a base year of 12 months from the date of award.
Notice text
This is a Notice of Intent, not a request for a quotation. A solicitation document will not be issued, and quotations will not be requested.
The National Institute of Health, Clinical Center (CC) intends to award a Firm-Fixed price purchase order to Illumina, Inc., San Diego, CA 92122 on a sole source basis to provide maintenance service for two (2) Illumina NextSeq™ 1000 Sequencers. The instruments are used for to perform high-throughput, next-generation sequencing to diagnose inherited immune disorders within the Department of Lab Medicine. The requirements for the HiSeq 1000 Silver Support Plan include full coverage for parts, labor, and travel; Reagent replacement upon HW failures; 1 PM; Remote Technical Support 18x5; 2 business day average on-site response; control SW and HW updates; On-site applications support; discounts on advanced training; remote monitoring available.
Illumina is the sole manufacturer and is the only known provider with access to performance verified component parts, spare parts, software, technical support, upgrades, and engineering resources to maintain the original operating specifications for the Illumina NextSeq™ 1000 Sequencer. The parts and services for this instrument are not available from third party sources. Only Illumina service engineers have the technical expertise and skills to troubleshoot and repair this instrument. Period of Performance shall be for a base year of twelve (12) months from date of award.
This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 – Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements.
The North American Industry Classification System (NAICS) code for this acquisition is 811210 with a large business standard size of $30.4 million.
This notice of intent to award is not a request for competitive quotations. Interested concerns capable of providing the same products or services as described in this notice may submit a capability statement outlining their capabilities. No solicitation is available. Information received will be evaluated for the purpose of determining whether to conduct a competitive procurement. Capability Statements must be received within the time set forth in this synopsis to be considered by the Government. A determination to compete this proposed contract based on responses to this notice is solely within the discretion of the Government.
Each response should include the following Business Information:
a. SAM UEI.
b. Company Name, address, POC, Phone and Email address
c. Current GSA Schedules or NAICS codes appropriate to this Award.
d. Capability Statement
Comments to this announcement may be submitted to the Clinical Center, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, electronically to the attention of Kimala Winfield, kimala.winfield@nih.gov or Malinda Dehner, dehnerm@cc.nih.gov by the due date and time marked in this notice.
Similar open opportunities
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity